Dettenkofer M, Ammon A, Astagneau P, Dancer SJ, Gastmeier P, Harbarth S, et al. Infection control – a European research perspective for the next decade. J Hosp Infect. 2011;77(1):7–10.
Tschudin SS, Frei R, Dangel M, Gratwohl A, Bonten M, Widmer AF. Not all patients with vancomycin-resistant enterococci need to be isolated. Clin Infect Dis. 2010;51(6):678–83.
Tietz A, Frei R, Widmer AF. Transatlantic spread of the USA300 clone of MRSA. N Engl J Med. 2005;353(5):532–3.
Liassine N, Frei R, Jan I, Auckenthaler R. Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol. 1998;36(7):1853–8.
Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A. Prevalence of vancomycin-resistant enterococci in Europe. European VRE Study Group. Eur J Clin Microbiol Infect Dis. 2000;19(11):816–22.
Gordts B, Van Landuyt H, Ieven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol. 1995;33:2842–6.
Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K. Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol. 1997;35(12):3166–70.
Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120(12):4332–41.
Widmer AF. Transmission of resistant bacteria in intensive care. N Engl J Med. 2011;365(8):763–5.
Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis. 2006;42(Suppl 1):S25–S34.
Thierfelder C, Keller PM, Kocher, C, Gaudenz R, Hobmach M, Bloember GV, Ruef C. Vancomycin-resistant Enterococcus – A multiple-strain outbreak of eight weeks duration at a Swiss tertiary care hospital. Swiss Med Wkly. 2012;142:w13554.
